|
|
SPOT ON
|
|
Globalisation of the clinical research: export of risks
|
|
|
NEW ON THE MARKET
|
|
Ranolazin (RANEXA) for angina pectoris
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
Mass vaccination with pneumococcal conjugate vaccine PREVENAR - first data from Europe
|
|
|
a-t READER'S QUESTIONS AND COMMENTS
|
|
Ginkgo biloba useful for dementia?
|
|
|
CURRENT ADR NETWORK REPORT
|
|
|
Nightmares on CSE inhibitors
|
|
|
IN BRIEF
|
|
Prasugrel, Lilly and FDA - exclusion of an expert following a phone call
|
|
|
SIDE EFFECTS
|
|
Long term metoclopramide: tardive dyskinesia
Guillain-Barré syndrome after HPV-vaccination
Tibolone (LIVIELLA) increases the risk of breast cancer recurrence
Efalizumab (RAPTIVA): suspension of marketing authorisation recommended
|
|